Web Analytics




Home Tags Posts tagged with "Milestone Payments"

Tag: Milestone Payments

Jacobio AstraZeneca licensing deal Cooley
Deal Highlights

Cooley advises Jacobio’s USD2bn licensing deal with AstraZeneca

Cooley has advised Jacobio Pharmaceuticals on a record-breaking USD 2.02 billion global licensing agreement with AstraZeneca

0
China Pharma Out-Licensing Deals
In focus

Out-licensing is in

China's out-licensing boom: legal experts share tips for seamless pharma deals

0

LATEST ON LAW.ASIA

MOST READ ON LAW.ASIA

ESG-due-diligence-for-Philippine-mining-and-energy-M&A

ESG due diligence for Philippine mining and energy M&A

By Recolito Ferdinand N Cantre Jr, Cristina Marie T Bello and Mikaela V Bernardino, Sarmiento Loriega Law Office
India GCC compliance frameworkvideo

Setting up a GCC in India

By Vikas Agarwal and Vivek Sadhale, LegaLogic Consulting
Marubeni Acquisition EagleRidge Energy II

Clifford Chance maps Japan Marubeni’s US natural gas buy

Gagan Kathuria Joins AnantLaw

Gagan Kathuria joins AnantLaw as corporate M&A partner

China’s first public commercial REITs

Firms steer debut of China’s first public commercial REITs

JILA ICC Asia-Pacific Conference

JILA backs first overseas ICC conference in outreach milestone

Correspondents

Arbitration Clause Drafting

Consent, clarity and arbitration clause lessons

By Hiral Gupta and Surabhi Sharan, Bharucha & Partners
India Green Channel Route

Green Channel Route: Gains and predictability

By Vandana Pai and Hardik Dave, Bharucha & Partners
Impact Investing Compliancevideo

Impact investing: Do use of proceeds clauses actually work?

By Mita Sood, Bharucha & Partners
Arbitration Due Process Limitsvideo

Policy, process and delay in arbitral challenges

By Sneha Jaisingh and Jaidhara Shah, Bharucha & Partners
Follow Law.asia
Law firms Awards Events Legal jobs • Post a job
About us Archive Subscribe Contact us
Please send any press releases, deal announcements, details of new hires, newsletters and any other news items to: news@law.asia
© Copyright 2026 Law.asia Limited. All rights reserved.

Follow us on LinkedIn

Follow now